Skip to main content
. 2021 May 12;12:649833. doi: 10.3389/fpsyt.2021.649833

Table 2.

The patient's scores on CAARS (in percentile rank) and Y-BOCS.

CAARS Y-BOCS
Diagnostic stage, before ADHD-specific treatment (medication: paroxetine and quetiapine) DSM-I = 98
DSM-Hy/I = 86
DSM-Total = 96
ADHD-Index = 88
Symptom Checklist:
Obsessions: 7/Compulsions: 7
Severity scale:
Obsessions: 8/Compulsions: 10
At the end of the first inpatient treatment (medication: ER MPH and sertraline) DSM-I = 10
DSM-Hy/I = 14
DSM-Total = 10
ADHD-Index = 5
Symptom checklist:
Obsessions: 1/Compulsions: 1
Severity scale:
Obsessions: 5/Compulsions: 2
During the second inpatient treatment (medication: sertraline, quetiapine, onset of ER MPH treatment after 14 days of atomoxetine intake) DSM-I = 54
DSM-Hy/I = 82
DSM-Total = 69
ADHD-Index = 76
Symptom checklist:
Obsessions: 4/Compulsions: 4
Severity scale:
Obsessions: 11/Compulsions: 9
After discharge from second inpatient treatment (medication: ER MPH, sertraline and quetiapine)
DSM-I = 38
DSM-Hy/I = 35
DSM-Total = 35
ADHD-Index = 42
Symptom checklist:
Obsessions: 2/Compulsions: 4
Severity scale:
Obsessions: 10/Compulsions: 8

ADHD, attention deficit hyperactivity disorder; ER MPH, extended-release methylphenidate; CAARS, Conners adult ADHD rating scales; DSM-I, DSM-IV inattentive symptoms; DSM-Hy/I, DSM-IV hyperactive–impulsive symptoms; DSM-Total, DSM-IV ADHD symptoms total; Y-BOCS, yale–brown obsessive compulsive scale.